Co-trimoxazole to reduce mortality, transplant, or unplanned hospitalisation in people with moderate to very severe idiopathic pulmonary fibrosis: the EME-TIPAC RCT

Wilson AM, Clark AB, Cahn A, Chilvers ER, Fraser W, Hammond M, et al.
Record ID 32015000726
Project Status: Completed
Year Published: 2021
Requestor: NIHR Health Technology Assessment programme
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England, United Kingdom
MeSH Terms
  • Anti-Bacterial Agents
  • Lung Transplantation
  • Anti-Infective Agents
  • Idiopathic Pulmonary Fibrosis
  • Trimethoprim, Sulfamethoxazole Drug Combination
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
Contact Email:
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.